IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4-Reference-Cited by-同舟云学术

IKBIP, a novel glioblastoma biomarker, maintains abnormal proliferation of tumor cells by inhibiting the ubiquitination and degradation of CDK4

Published:2023-01 Issue:1 Volume:1869 Page:166571
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Li Kaishu,Huang Guanglong,Wang Ziyu,Yang Runwei,Zhang Wanghao,Ni Bowen,Guan Jingyu,Yi Guozhong,Li Zhiyong,Zhu Qihui,Peng Qian,Yang Lunhao,Qi Ling,Liu Yawei

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference44 articles.

1. Adult glioblastoma;Alexander;J. Clin. Oncol.,2017

2. The 2021 WHO classification of tumors of the central nervous system: a summary;Louis;Neuro-Oncology,2021

3. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity;Calandrini;Nat. Commun.,2020

4. Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps;Abbruzzese;J. Exp. Clin. Cancer Res.,2020

5. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EGFLAM exhibits oncogenic activity and shows promise as a prognostic biomarker and therapeutic target in glioblastoma;International Immunopharmacology;2024-09

2. Development and validation of a risk prognostic model based on the H. pylori infection phenotype for stomach adenocarcinoma;Heliyon;2024-09

3. IKBIP promotes tumor development via the akt signaling pathway in esophageal squamous cell carcinoma;BMC Cancer;2024-06-24

4. DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment;Biomedicine & Pharmacotherapy;2024-05

5. IKIP downregulates THBS1/FAK signaling to suppress migration and invasion by glioblastoma cells;Oncology Research;2024